Revaprazan Hydrochloride CAS 178307-42-1 Agbeyewo ≥99.0% API Factory High Purity
Orukọ Kemikali: Revaprazan Hydrochloride;Revaprazan HCL
CAS: 178307-42-1
API Didara Giga, Iṣelọpọ Iṣowo
Orukọ Kemikali | Revaprazan Hydrochloride |
Awọn itumọ ọrọ sisọ | Revaprazan HCL |
Nọmba CAS | 178307-42-1 |
NỌMBA CAT | RF-API48 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
Fọọmu Molecular | C22H24ClFN4 |
Òṣuwọn Molikula | 398.904 |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Funfun tabi Pa-White Crystalline Powder |
Solubility | Tiotuka larọwọto ni chloroform, dichlormeth;Soluble ni acetic acid;Diẹ tiotuka ni kẹmika, DMSO;O fee tiotuka ni acetone, ACN;Fere kii ṣe tiotuka ni ojutu 0.1mol/L NaOH.0.1mol / L HCL ojutu. |
Idanimọ | Yẹ ki o ni idahun daadaa λ max 271nm, 205nm IR |
Ojuami Iyo | 219.0 ~ 222.0 ℃ |
wípé ati Awọ | Yẹ ki o jẹ kedere ati ti ko ni awọ ni dichlormeth |
Kloride | ≤8.93% |
Aimọ Kanṣoṣo | ≤0.10% |
Lapapọ Awọn Aimọ | ≤0.50% |
Pipadanu lori Gbigbe | ≤0.50% |
Aloku lori Iginisonu | ≤0.10% |
Sulfate | ≤20ppm |
Arsenic | ≤10ppm |
Awọn irin Heavy | ≤10ppm |
Ayẹwo | ≥99.0% |
Igbeyewo Standard | Standard Enterprise |
Lilo | Ohun elo elegbogi ti nṣiṣe lọwọ (API) |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
Shanghai Ruifu Chemical Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti Revaprazan Hydrochloride (CAS: 178307-42-1) pẹlu didara to gaju.Revaprazan Hydrochloride dinku ikosile COX-2 ati pe o ni awọn iṣẹ iṣe egboogi-iredodo pataki ni ikolu H. pylori.Revaprazan Hydrochloride ni itọju ti ọgbẹ duodenal, ọgbẹ inu ati gastritis.
Revaprazan Hydrochloride (ti a tun mọ ni awọn inhibitors proton pump reversible, potasiomu ifigagbaga acid blockers, p-CABs) jẹ iran tuntun ti awọn inhibitors fifa proton ati awọn inhibitors ifigagbaga acid potasiomu ti o wa ni iṣowo tabi awọn alatako fifa acid ni agbaye.Ti dagbasoke nipasẹ ile-iṣẹ South Korea Yuhan ati pẹlu awọn ẹtọ ohun-ini imọ-jinlẹ, GLAxoSmithKline ti gba idagbasoke agbaye ati awọn iwe-aṣẹ titaja fun oogun ni ita South Korea ati North Korea.Oogun naa jẹ ifọwọsi nipasẹ South Korean FDA ni ọdun 2007 lati ṣe itọju awọn ọgbẹ duodenal ati gastritis.